Nancy Schlichting - Hill Rom Independent Director

Director

Ms. Nancy M. Schlichting is Independent Director of the Company. Ms. Schlichting is the retired President and Chief Executive officer of Henry Ford Health System in Detroit, Michigan, serving in this role from June, 2003 to January, 2017. She joined HFHS in 1998 as Senior Vice President and Chief Administrative Officer, and was promoted to Executive Vice President and Chief Operating Officer from 1999 to 2003, and President and Chief Executive Officer of Henry Ford Hospital from 2001 to 2003. She currently serves as a director of Walgreens Boots Alliance, a director on the board of directors of Encompass Health, and a trustee of Kresge Foundation, Michigan State University, the Detroit Symphony Orchestra, Duke University and vicechair of the Duke University Health System Board. since 2017.
Age 65
Tenure 7 years
Phone812 934-8189
Webwww.hillrom.com
Schlichting career in healthcare administration spans more than 35 years in seniorlevel executive roles. She is credited with leading HFHS through a dramatic financial turnaround, and for awardwinning customer service, quality and diversity initiatives, including HFHS being the recipient of the 2011 Malcolm Baldrige National Quality Award. Her significant healthcare leadership background, and her comprehensive knowledge of finance and accounting gained by education, experience and service on audit committees for more than a decade provide the Board with additional depth and invaluable insights.

Hill Rom Management Efficiency

The company has Return on Asset of 6.13 % which means that on every $100 spent on assets, it made $6.13 of profit. This is considered to be average in the sector. In the same way, it shows a return on shareholders' equity (ROE) of 13.78 %, implying that it generated $13.78 on every 100 dollars invested. Hill Rom's management efficiency ratios could be used to measure how well Hill Rom manages its routine affairs as well as how well it operates its assets and liabilities.
The company has 2.16 B in debt with debt to equity (D/E) ratio of 1.15, which is OK given its current industry classification. Hill Rom Holdings has a current ratio of 1.35, which is typical for the industry and considered as normal. Debt can assist Hill Rom until it has trouble settling it off, either with new capital or with free cash flow. So, Hill Rom's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Hill Rom Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Hill to invest in growth at high rates of return. When we think about Hill Rom's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Lynn AtchisonQ2 Holdings
58
Deng ChenKingdee International Software
37
Raymond AnstissFidus Investment Corp
50
Jeffrey DiehlQ2 Holdings
50
Shahid BurkiNetSol Technologies
75
Mark CatonNetSol Technologies
65
Malea FarsaiNetSol Technologies
54
Michael BrownQ2 Holdings
44
Gary BiddleKingdee International Software
63
Jeffrey BilbreyNetSol Technologies
43
James OfferdahlQ2 Holdings
64
Chen ZhangKingdee International Software
50
Carl SchaperQ2 Holdings
66
Cheng WuKingdee International Software
75
Michael MaplesQ2 Holdings
75
Edward TuneFidus Investment Corp
N/A
John MazzarinoFidus Investment Corp
63
Lynn TysonQ2 Holdings
N/A
Eugen BeckertNetSol Technologies
67
Asad GhauriNetSol Technologies
47
Henry TolentinoNetSol Technologies
N/A
Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. Hill-Rom Holdings, Inc. was founded in 1915 and is headquartered in Chicago, Illinois. Hill-Rom Holdings operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 10000 people. Hill Rom Holdings (HRC) is traded on New York Stock Exchange in USA and employs 10,000 people.

Management Performance

Hill Rom Holdings Leadership Team

Elected by the shareholders, the Hill Rom's board of directors comprises two types of representatives: Hill Rom inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hill. The board's role is to monitor Hill Rom's management team and ensure that shareholders' interests are well served. Hill Rom's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hill Rom's outside directors are responsible for providing unbiased perspectives on the board's policies.
Amy Dodrill, Senior Vice President and President Surgical Solutions
Michael Macek, VP and Treasurer
Stacy Seng, Independent Director
Enxing Seng, Director
Nancy Schlichting, Independent Director
Ilana Shulman, Chief Compliance Officer
William Dempsey, Non-Executive Independent Chairman of the Board
Felicia Norwood, Independent Director
Taylor Smith, Senior Vice President and Presidentident - Surgical and Respiratory Care
Richard Wagner, Chief Accounting Officer, Vice President, Controller
Anjana Harve, Chief Information Officer
Timothy Lawrence, Senior Vice President - Operations
Carlos Alonso, President Senior Vice President
Kenneth Meyers, Chief Human Resource Officer, Senior Vice President
Dirk Ehlers, Senior Vice President and Presidentident - Surgical Solutions
Francisco Vega, Senior Vice President - President Surgical Solutions
Eduardo Menasce, Independent Director
Jason Richardson, Vice President Corporate Controller
Carlyn Solomon, COO
Deborah Rasin, Senior Vice President Chief Legal Officer, Secretary
Carlos Marum, Senior Vice President and Presidentident - Hill-Rom International
Michiel Zwaan, Chief Human Resource Officer, Senior Vice President
John Greisch, CEO and President Director and Member of Mergers and Acquisitions Committee
Mary Ladone, Senior Vice President - Corporate Development, Strategy and Investor Relations
John Groetelaars, President, Chief Executive Officer, Director
Gregory Moore, Independent Director
Rolf Classon, Independent Chairman of the Board
Andreas Frank, Senior Vice President, President - Front Line Care Business
Mary Garrett, Independent Director
Ronald Malone, Lead Independent Director
Michael Murphy, Senior Vice President - Quality Assurance and Regulatory Affairs
James Giertz, Independent Director
Alton Shader, Sr. VP and President of Welch Allyn and President of Front Line Care
Steven Strobel, CFO and Sr. VP
Stanley Burhans, Vice President Corporate Controller
William Kucheman, Independent Director
Charles Golden, Independent Director
Paul Johnson, Senior Vice President and Presidentident of Patient Support Systems
Barbara Bodem, Chief Financial Officer, Senior Vice President
Gary Ellis, Independent Director
Brian Lawrence, Senior Vice President - Innovation and Connectivity and Chief Technology Officer
Susan Lichtenstein, Chief Legal Officer, Sr. VP of Corporate Affairs and Secretary
Kevin McCulloch, President Senior Vice President
Richard Marritt, Senior Vice President Chief Marketing Officer
SueJean Lin, Senior Vice President CIO
Richard Keller, Chief Accounting Officer, VP and Controller

Hill Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Hill Rom a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Consideration for investing in Hill Stock

If you are still planning to invest in Hill Rom Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hill Rom's history and understand the potential risks before investing.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings